Find a TenderAwarded

Published 29 Apr 2022, 10:28 BST

Official UK procurement notice

NP90722m Brodalumab (Kyntheum®) · UK public procurement notice

Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") (NHS & healthcare)

Framework agreementGoodsNegotiated without publication of a contract notice

Sectors: Medical Devices & Pharma (33) Delivery: Scotland (UKM)

Framework ceiling (notional)Value not publishedframework ceiling, not attributable revenue

Awarded 29 Apr 2022

What is being bought

Published requirement description

Supply of Brodalumab (Kyntheum®) to NHS Scotland

CPV: Pharmaceutical products

The lotProcurement structure

single lot · no lot value published

Lot #1Supply of Brodalumab (Kyntheum®) pre-filled syringes to NHS Scotland

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

33600000 Pharmaceutical products

What it takes to win
i
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more

What this means for your bid

“NP90722m Brodalumab (Kyntheum®)” is a framework: the contest is a place on its panel, not a single contract.

Procedure terms & legal framework

From the official record · publisher note attached

Procedure method: Negotiated without publication of a contract notice
Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Goods
Notice status: Awarded
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Framework agreement
Who may use this agreement: Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type: Competitive procedure
GPA / WTO covered: Yes (GPA)
Recurring procurement: Unspecified in notice
First published: 29 Apr 2022, 10:28 BST
Last source update: 29 Apr 2022, 10:28 BST
FTS notice number: 2022/S 000-011069
Classification (CPV): Pharmaceutical products
Delivery area: Scotland (UKM)
Official registry OCID: ocds-h6vhtk-0331da Find a Tender

Why no open competition: The works, supplies or services can be provided only by a particular economic operator due to protection of exclusive rights, including intellectual property rights
Published justification: The medicine awarded to this framework agreement is, and will remain to be, protected by patent for the duration of the framework agreement.

Review and risk notes

Review procedure: The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the authority despatches the VEAT notice and the date on which the authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer. The bringing of court proceedings against the authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.

Publisher note: The total value in Sections II.1.7 and V.2.4 refers to the twenty-four (24) months initial period and twenty-four (24) months extension period. (SC Ref:691188)

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Suppliers appointed 1admitted to the panel · see the list ↓

Contracts signed 1latest 29 Apr 2022

1 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.

Contracts

Contract 011069-2022-1
Signed
29 Apr 2022
Value
£1,225,384
Status
active

Contracting authority & participating public bodies

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

Contracting authorityNHS & healthcareBody governed by public lawHealth Gyle Square (NSS Head Office), 1 South Gyle Crescent, Edinburgh, UK, EH12 9EBContact name, email, phone

Dispute resolution & review bodies

Edinburgh Sheriff CourtReview body EdinburghContact email, phone

Framework contractors & participating bidders

1 commercial party on the notice

LEO PharmaFramework contractor Horizon, Honey Lane,, Hurley, UK, SL6 6RJContact phone

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.